FindTrial
Sign In

Value of ultrasound to the prediction of restenosis of arteriovenous fistula after pereutaneous transluminal angioplasty in patients undergoing hemodialysis

Value of ultrasound to the prediction of restenosis of arteriovenous fistula after pereutaneous transluminal angioplasty in patients undergoing hemodialysis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500097473
Enrollment
Unknown
Registered
2025-02-19
Start date
2025-03-10
Completion date
Unknown
Last updated
2025-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic renal failure

Interventions

The Restenosis group:None
The final patency group:

Sponsors

The First Affiliated Hospital of PLA Army Medical University (Southwest Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. age 18 to 90 years; 2. autologous AVF hemodialysis patient; 3. with PTA and preoperative ultrasound.;

Exclusion criteria

Exclusion criteria: 1. the AVF single reflux venous cephalic venous arch stenosis; 2. with malignant tumor; 3. severe dysfunction of vital organs;? pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
AVF stenosis length;—

Countries

China

Contacts

Public ContactShu Qipei

The First Affiliated Hospital of PLA Army Medical University (Southwest Hospital)

shuqipeiy@163.com+86 136 4835 5971

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026